 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Use of Common Laboratory Tests To Identify People with Insulin Resistance
18 November 2003 | Volume 139 Issue 10 | Page I-16
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant." It is in the 18 November 2003 issue of Annals of Internal Medicine (volume 139, pages 802-809). The authors are T. McLaughlin, F. Abbasi, K. Cheal, J. Chu, C. Lamendola, and G. Reaven.
What is the problem and what is known about it so far?
Insulin is a substance that the pancreas makes to help the body store energy from food. People with type 2 diabetes mellitus make plenty of insulin, but their bodies cannot use it normally, resulting in high blood sugar levels. Some people do not have type 2 diabetes but have "insulin resistance." People with insulin resistance do not have the high blood sugar levels that occur in people with type 2 diabetes, but their bodies must produce large amounts of insulin to keep sugar levels normal. Insulin resistance can lead to type 2 diabetes and heart disease. Many people with insulin resistance are overweight. Losing weight can improve insulin resistance and prevent type 2 diabetes and heart disease. Knowing whether overweight patients had insulin resistance could help doctors tell who would benefit most from weight loss. Unfortunately, the standard testing for insulin resistance is a complicated laboratory procedure.
Why did the researchers do this particular study?
To see how well common tests can identify patients with insulin resistance.
Who was studied?
258 overweight volunteers who had participated in the researchers' previous studies and had normal blood pressure and no diabetes.
How was the study done?
The researchers had completed standard testing for insulin resistance in the study patients, so they knew who had insulin resistance. The researchers also had information on the patients' body mass index (a measure of body size that considers weight and height) and blood tests for levels of sugar, insulin, and lipids. The lipid tests included total cholesterol, high-density lipoprotein (HDL) cholesterol, and triglyceride levels. The researchers saw how well each of the following measures predicted insulin resistance: ratio of triglyceride to HDL cholesterol, triglyceride level, insulin level, ratio of total cholesterol to HDL cholesterol, body mass index, HDL cholesterol level, glucose level, and total cholesterol level.
What did the researchers find?
The tests that were most useful for identifying patients who had insulin resistance were triglyceride level, ratio of triglyceride to HDL cholesterol, and insulin level. However, no test was perfect and all tests missed some people with insulin resistance and incorrectly labeled some people as insulin resistant when they were not. In addition, insulin levels are not standardized across laboratories, so similar values obtained from another laboratory might or might not indicate insulin resistance. For this reason, the authors favor the lipid markers (triglyceride level and the ratio of triglyceride to HDL cholesterol) of insulin resistance.
What were the limitations of the study?
This study involved research volunteers, so the results might not apply to overweight people in general. More important, this study does not prove that directing weight loss effort according to levels of triglycerides and HDL cholesterol would actually decrease the development of type 2 diabetes and heart disease among overweight people.
What are the implications of the study?
Since it is easy to measure triglyceride and HDL cholesterol levels, doctors might consider using these tests to predict whether their overweight patients are likely to have insulin resistance. However, further study is needed to know whether such testing of overweight people is a good strategy for decreasing the development of type 2 diabetes and heart disease.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  J Polak, Z Kovacova, C Holst, C Verdich, A Astrup, E Blaak, K Patel, J M Oppert, D Langin, J A Martinez, et al. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. Eur. J. Endocrinol., April 1, 2008; 158(4): 533 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Porrini, P. Delgado, A. Alvarez, M. Cobo, L. Perez, J. M. Gonzalez-Posada, L. Hortal, R. Gallego, J. J. Garcia, M. Checa, et al. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1436 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Jacobs, M. E. Martinez, D. S. Alberts, E. L. Ashbeck, S. M. Gapstur, P. Lance, and P. A. Thompson Plasma Insulin-Like Growth Factor I Is Inversely Associated with Colorectal Adenoma Recurrence: A Novel Hypothesis Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 300 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vigil, P. Contreras, J. L. Alvarado, A. Godoy, A. M. Salgado, and M. E. Cortes Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome Hum. Reprod., November 1, 2007; 22(11): 2974 - 2980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Riserus, J. Arnlov, and L. Berglund Long-Term Predictors of Insulin Resistance: Role of lifestyle and metabolic factors in middle-aged men Diabetes Care, November 1, 2007; 30(11): 2928 - 2933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Boyko and C. C. Jensen Do We Know What Homeostasis Model Assessment Measures?: If not, does it matter? Diabetes Care, October 1, 2007; 30(10): 2725 - 2728. [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Lien, A. J. Brown, J. D. Ard, C. Loria, T. P. Erlinger, A. C. Feldstein, P.-H. Lin, C. M. Champagne, A. C. King, H. L. McGuire, et al. Effects of PREMIER Lifestyle Modifications on Participants With and Without the Metabolic Syndrome Hypertension, October 1, 2007; 50(4): 609 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Sung, M. C. Ryan, B. S. Kim, Y. K. Cho, B. I. Kim, and G. M. Reaven Relationships Between Estimates of Adiposity, Insulin Resistance, and Nonalcoholic Fatty Liver Disease in a Large Group of Nondiabetic Korean Adults Diabetes Care, August 1, 2007; 30(8): 2113 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, L. E. Wagenknecht, A. Festa, R. B. D'Agostino Jr., and S. M. Haffner Alanine Aminotransferase and Directly Measured Insulin Sensitivity in a Multiethnic Cohort: The Insulin Resistance Atherosclerosis Study Diabetes Care, July 1, 2007; 30(7): 1819 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Reaven The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre? J. Am. Coll. Nutr., June 1, 2007; 26(3): 191 - 195. [Full Text] [PDF]
|
|
|
|
|
|
C. Beysen, E. J. Murphy, T. McLaughlin, T. Riiff, C. Lamendola, H. C. Turner, M. Awada, S. M. Turner, G. Reaven, and M. K. Hellerstein Whole-Body Glycolysis Measured by the Deuterated-Glucose Disposal Test Correlates Highly With Insulin Resistance In Vivo Diabetes Care, May 1, 2007; 30(5): 1143 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Ryan, F. Abbasi, C. Lamendola, S. Carter, and T. L. McLaughlin Serum Alanine Aminotransferase Levels Decrease Further With Carbohydrate Than Fat Restriction in Insulin-Resistant Adults Diabetes Care, May 1, 2007; 30(5): 1075 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Barzilay, C. Blaum, T. Moore, Q. Li Xue, C. H. Hirsch, J. D. Walston, and L. P. Fried Insulin Resistance and Inflammation as Precursors of Frailty: The Cardiovascular Health Study Arch Intern Med, April 9, 2007; 167(7): 635 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. McLaughlin, F. Abbasi, C. Lamendola, and G. Reaven Heterogeneity in the Prevalence of Risk Factors for Cardiovascular Disease and Type 2 Diabetes Mellitus in Obese Individuals: Effect of Differences in Insulin Sensitivity Arch Intern Med, April 9, 2007; 167(7): 642 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kahn Metabolic Syndrome: Is It a Syndrome? Does It Matter? Circulation, April 3, 2007; 115(13): 1806 - 1811. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Beaser and P. Levy A Work in Progress, but a Useful Construct Circulation, April 3, 2007; 115(13): 1812 - 1818. [Full Text] [PDF]
|
|
|
|
|
|
C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven Trends in hyperinsulinemia among nondiabetic adults in the u.s. Diabetes Care, November 1, 2006; 29(11): 2396 - 2402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Simo, A. Lecube, J. Genesca, J. I. Esteban, and C. Hernandez Sustained Virological Response Correlates With Reduction in the Incidence of Glucose Abnormalities in Patients With Chronic Hepatitis C Virus Infection. Diabetes Care, November 1, 2006; 29(11): 2462 - 2466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.D.H. Malnick and H. Knobler The medical complications of obesity QJM, September 1, 2006; 99(9): 565 - 579. [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Kim, L. Chunawala, R. Linde, and G. M. Reaven Comparison of the 1997 and 2003 American Diabetes Association Classification of Impaired Fasting Glucose: Impact on Prevalence of Impaired Fasting Glucose, Coronary Heart Disease Risk Factors, and Coronary Heart Disease in a Community-Based Medical Practice J. Am. Coll. Cardiol., July 18, 2006; 48(2): 293 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kahn The Metabolic Syndrome (Emperor) Wears No Clothes Diabetes Care, July 1, 2006; 29(7): 1693 - 1696. [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Third Annual World Congress on the Insulin Resistance Syndrome: Mediators, antecedents, and measurement Diabetes Care, July 1, 2006; 29(7): 1700 - 1706. [Full Text] [PDF]
|
|
|
|
 |
|
 G. M Reaven The metabolic syndrome: is this diagnosis necessary? Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1237 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ovbiagele, J. L. Saver, M. J. Lynn, M. Chimowitz, and for the WASID Study Group Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis Neurology, May 9, 2006; 66(9): 1344 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Davidson, J. K. Hix, D. G. Vidt, and D. J. Brotman Association of Impaired Diurnal Blood Pressure Variation With a Subsequent Decline in Glomerular Filtration Rate. Arch Intern Med, April 24, 2006; 166(8): 846 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Cordero and E Alegria Sex differences and cardiovascular risk Heart, February 1, 2006; 92(2): 145 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Reaven and T. McLaughlin Why the Plasma TG/HDL-C Concentration Ratio Does Not Predict Insulin Resistance in African Americans Arch Intern Med, January 23, 2006; 166(2): 249 - 249. [Full Text] [PDF]
|
|
|
|
|
|
A. E. Sumner Why the Plasma TG/HDL-C Concentration Ratio Does Not Predict Insulin Resistance in African Americans--Reply Arch Intern Med, January 23, 2006; 166(2): 249 - 250. [Full Text] [PDF]
|
|
|
|
|
|
H. M. Farin, F. Abbasi, and G. M Reaven Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults Am. J. Clinical Nutrition, January 1, 2006; 83(1): 47 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pladevall, B. Singal, L. K. Williams, C. Brotons, H. Guyer, J. Sadurni, C. Falces, M. Serrano-Rios, R. Gabriel, J. E. Shaw, et al. A Single Factor Underlies the Metabolic Syndrome: A confirmatory factor analysis Diabetes Care, January 1, 2006; 29(1): 113 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Zachary. T Bloomgarden Developments in Diabetes and Insulin Resistance Diabetes Care, January 1, 2006; 29(1): 161 - 167. [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, A. J. Karter, K. Williams, A. Festa, R. B. D'Agostino Jr, L. E. Wagenknecht, and S. M. Haffner Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study Circulation, December 13, 2005; 112(24): 3713 - 3721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kahn, J. Buse, E. Ferrannini, and M. Stern The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care, September 1, 2005; 28(9): 2289 - 2304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Reaven Counterpoint: Just Being Alive Is Not Good Enough Clin. Chem., August 1, 2005; 51(8): 1354 - 1357. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dokras, M. Bochner, E. Hollinrake, S. Markham, B. VanVoorhis, and D. H. Jagasia Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome Obstet. Gynecol., July 1, 2005; 106(1): 131 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Sumner, K. B. Finley, D. J. Genovese, M. H. Criqui, and R. C. Boston Fasting Triglyceride and the Triglyceride-HDL Cholesterol Ratio Are Not Markers of Insulin Resistance in African Americans Arch Intern Med, June 27, 2005; 165(12): 1395 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wahrenberg, K. Hertel, B.-M. Leijonhufvud, L.-G. Persson, E. Toft, and P. Arner Use of waist circumference to predict insulin resistance: retrospective study BMJ, June 11, 2005; 330(7504): 1363 - 1364. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Reaven Dr. Reaven responds: Clin. Chem., June 1, 2005; 51(6): 1083 - 1084. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Reaven The Metabolic Syndrome: Requiescat in Pace Clin. Chem., June 1, 2005; 51(6): 931 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Stern, K. Williams, E. Ferrannini, R. A. DeFronzo, C. Bogardus, and M. P. Stern Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements Diabetes, February 1, 2005; 54(2): 333 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper, and M. Roden Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity Clin. Chem., December 1, 2004; 50(12): 2316 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs Metabolic Syndrome: In search of a clinical role Diabetes Care, November 1, 2004; 27(11): 2761 - 2763. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Rizvi Metabolic Markers of Insulin Resistance in Overweight Persons Ann Intern Med, August 3, 2004; 141(3): 243 - 243. [Full Text] [PDF]
|
|
|
|
|
|
U. Riserus, J. Arnlov, K. Brismar, B. Zethelius, L. Berglund, and B. Vessby Sagittal Abdominal Diameter Is a Strong Anthropometric Marker of Insulin Resistance and Hyperproinsulinemia in Obese Men Diabetes Care, August 1, 2004; 27(8): 2041 - 2046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Carr, K. M. Utzschneider, R. L. Hull, K. Kodama, B. M. Retzlaff, J. D. Brunzell, J. B. Shofer, B. E. Fish, R. H. Knopp, and S. E. Kahn Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome Diabetes, August 1, 2004; 53(8): 2087 - 2094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Vinicor and B. Bowman The Metabolic Syndrome: The Emperor Needs Some Consistent Clothes: Response to Davidson and Alexander Diabetes Care, May 1, 2004; 27(5): 1243 - 1243. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Shishehbor, B. J. Hoogwerf, and M. S. Lauer Association of Triglyceride-to-HDL Cholesterol Ratio With Heart Rate Recovery Diabetes Care, April 1, 2004; 27(4): 936 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Reaven Insulin Resistance, Cardiovascular Disease, and the Metabolic Syndrome: How well do the emperor's clothes fit? Diabetes Care, April 1, 2004; 27(4): 1011 - 1012. [Full Text] [PDF]
|
|
|
|
|
|
I. Malik JournalScan Heart, February 1, 2004; 90(2): 235 - 236. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
